EFTR Company Profile and Key Details
eFFECTOR Therapeutics, Inc.
EFTR Stock Price Chart
Stock Price Today
eFFECTOR Therapeutics, Inc. (EFTR) stock remained unchanged at $0.00 a share on NASDAQ. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 2clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was founded in 2012 and is headquartered in Solana Beach, California.
Company Information
| Employees | 14 |
| Beta | 0.8 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) stock price is $0.00 in the last trading session. During the trading session, EFTR stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in EFTR stock occurred in the recent session was 0% while the dollar amount for the price change in EFTR stock was -.
The NASDAQ listed EFTR is part of Biotechnology industry that operates in the broader Healthcare sector. eFFECTOR Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Douglas Warner M.D.
Chief Medical Officer
Dr. Stephen T. Worland Ph.D.
Chief Executive Officer, Pres & Director
Mr. Michael Byrnes M.B.A.
Chief Financial Officer
Dr. Davide Ruggero Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
Dr. Mayank J. Gandhi M.D.
Chief Bus. Officer
Dr. Siegfried Reich Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
EFTR's closing price is 100% higher than its 52-week low of $0.00 where as its distance from 52-week high of $17.75 is -100%.
Number of EFTR employees currently stands at 14.
Official Website of EFTR is: https://effector.com
EFTR could be contacted at phone 858 925 8215 and can also be accessed through its website. EFTR operates from 142 North Cedros Avenue, Solana Beach, CA 92075, United States.
EFTR stock volume for the day was 720 shares. The average number of EFTR shares traded daily for last 3 months was 10.81K.
The market value of EFTR currently stands at $941.00 with its latest stock price at $0.00 and 4.7M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com